Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi Huarui Pharmaceutical is a leading clinical nutrition company in China, originally established in 1982 as the first pharmaceutical joint venture in the country. Now a key part of the Fresenius Kabi group, the company specializes in the development and production of parenteral and enteral nutrition products, as well as intravenous drugs and infusion therapies. Its portfolio includes well-known brands for amino acids, fat emulsions, and vitamins used in critical care, oncology, and surgery. The company operates a large-scale manufacturing base in Wuxi, Jiangsu Province, and maintains a dominant market position in the Chinese clinical nutrition sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius Kabi华瑞制药有限公司.